US Bancorp’s Whitehawk Therapeutics WHWK Stock Holding History

US Bancorp’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3K	Hold	3,333	–	–	﹤0.01%	3312
2026 Q1	$11.5K	Hold	3,333	–	–	﹤0.01%	3310
2025 Q4	$8.07K	Hold	3,333	–	–	﹤0.01%	3399
2025 Q3	$6.33K	Hold	3,333	–	–	﹤0.01%	3464
2025 Q2	$6.23K	Hold	3,333	–	–	﹤0.01%	3570
2025 Q1	$5.93K	Hold	3,333	–	–	﹤0.01%	3608
2024 Q4	$10.5K	Hold	3,333	–	–	﹤0.01%	3393
2024 Q3	$6.87K	Hold	3,333	–	–	﹤0.01%	3478
2024 Q2	$4.87K	Hold	3,333	–	–	﹤0.01%	3523
2024 Q1	$7.8K	Hold	3,333	–	–	﹤0.01%	3412
2023 Q4	$6.73K	Hold	3,333	–	–	﹤0.01%	3439
2023 Q3	$16.1K	Hold	3,333	–	–	﹤0.01%	2980
2023 Q2	$22.8K	Hold	3,333	–	–	﹤0.01%	2911
2023 Q1	$24.1K	Hold	3,333	–	–	﹤0.01%	2890
2022 Q4	$42.8K	Hold	3,333	–	–	﹤0.01%	2618
2022 Q3	$47K	Hold	3,333	–	–	﹤0.01%	2578
2022 Q2	$41K	Hold	3,333	–	–	﹤0.01%	2691
2022 Q1	$57K	Hold	3,333	–	–	﹤0.01%	2557
2021 Q4	$80K	Hold	3,333	–	–	﹤0.01%	2410
2021 Q3	$98K	Hold	3,333	–	–	﹤0.01%	2313
2021 Q2	$85K	Hold	3,333	–	–	﹤0.01%	2413
2021 Q1	$65K	Hold	3,333	–	–	﹤0.01%	2482
2020 Q4	$49K	Hold	3,333	–	–	﹤0.01%	2525
2020 Q3	$75K	Hold	3,333	–	–	﹤0.01%	2225
2020 Q2	$63K	Hold	3,333	–	–	﹤0.01%	2333
2020 Q1	$27K	Hold	3,333	–	–	﹤0.01%	2636
2019 Q4	$31K	Hold	3,333	–	–	﹤0.01%	2705
2019 Q3	$34K	Hold	3,333	–	–	﹤0.01%	2634
2019 Q2	$46K	Buy	+3,333	New	+$50.5K	﹤0.01%	2568

Other funds holding WHWK

Yu Fan $108M AUM 137.54% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $136M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

US Bancorp's WHWK Position: Q2 2026 in Review

US Bancorp held its Whitehawk Therapeutics (WHWK) position steady in Q2 2026 at 3,333 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3312.

US Bancorp first reported a position in WHWK in Q2 2019 and has held it in 29 quarters since. The position peaked at $98K in Q3 2021. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

US Bancorp held 3,333 shares of Whitehawk Therapeutics worth $15.3K as of Q2 2026.
US Bancorp left its Whitehawk Therapeutics share count unchanged in Q2 2026.
Whitehawk Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3312 holding.
US Bancorp first reported a position in Whitehawk Therapeutics in Q2 2019 and has held it in 29 quarters since.
US Bancorp's Whitehawk Therapeutics position peaked at $98K in Q3 2021.
77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.